Viewing Study NCT01561456

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:29 PM
Ignite Modification Date: 2026-01-04 @ 3:45 AM
Study NCT ID: NCT01561456
Status: COMPLETED
Last Update Posted: 2013-12-05
First Post: 2012-03-05
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Study of AXL1717 Compared to Docetaxel to Treat Squamous Cell Carcinoma or Adenocarcinoma of the Lung
Sponsor: Axelar AB
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Non-small-cell Lung Cancer View
None Squamous Cell Carcinoma View
None Adenocarcinoma of the Lung View
Keywords:

Keywords

Keyword Brief Keyword Text View
None non-small-cell lung cancer View
None squamous cell carcinoma View
None adenocarcinoma of the lung View
None IGF-1 inhibitor View
None docetaxel View
None AXL1717 View
None NSCLC View
None SCC View
None AC View